Emergent (EBS) to Retain TRU-016 Rights Following Collaboration Termination w/ Abbott (ABT)
Go back to Emergent (EBS) to Retain TRU-016 Rights Following Collaboration Termination w/ Abbott (ABT)| Abbott Laboratories (NYSE: ABT) | Delayed: 116.14 +2.00 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $114.14 | 52 Week High | $46.38 | |||
| Open | $114.02 | 52 Week Low | $36.00 | |||
| Day High | $116.28 | P/E | 77.43 | |||
| Day Low | $113.45 | EPS | $1.50 | |||
| Volume | 2,459,284 | |||||
| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 4.90 +0.08 (1.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.82 | 52 Week High | $44.38 | |||
| Open | $4.79 | 52 Week Low | $24.47 | |||
| Day High | $4.97 | P/E | 245.00 | |||
| Day Low | $4.75 | EPS | $0.02 | |||
| Volume | 306,192 | |||||
